Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)

Hong Kong · Delayed Price · Currency is HKD

16.35

+0.63 (4.01%)

Sep 30, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Production and Sale of Biological Products and The Provision of Related Services	2.45B	2.68B	2.63B	2.10B	1.75B
Total	2.45B	2.68B	2.63B	2.10B	1.75B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Mainland China	2.04B	2.25B	2.18B	1.70B	1.54B
Europe	155.10M	154.22M	136.05M	140.81M	66.97M
United States of America (USA)	112.46M	137.78M	120.28M	103.72M	82.92M
Other Regions and Countries	141.96M	141.79M	196.77M	159.83M	57.64M
Total	2.45B	2.68B	2.63B	2.10B	1.75B